Redhill Biopharma Ltd operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Redhill Biopharma Ltd with three other
miscellaneous service companies in Middle East:
Collplant Holdings Ltd
sales of 18.03 million Israel Shekels [US$5.20 million]
(6.30 million Israel Shekels [US$1.82 million]
of which 94%
was Agricultural Crops), and
Kitov Pharma Ltd
(3.60 million Israel Shekels [US$1.04 million]
of which 100%
was Pain and Hypertension).
Redhill Biopharma Ltd reported sales of 30.14 million Israel Shekels (US$8.70 million)
December of 2018.
increase of 110.6%
versus 2017, when the company's sales were 14.31 million Israel Shekels.
This was the third consecutive year of growth at Redhill Biopharma Ltd.